August 14, 2026

Resistance Training Volume and Muscle Growth: The Dose Response Evidence for Sarcopenic Obesity

By Dr. Zakira Naureen, Associate Professor, University of Nizwa
Exercise Body Composition Young Adults

In Simple Terms

  • Why “just do more sets” is not quite as simple as it sounds
  • How many weekly sets the strongest evidence actually supports for muscle growth
  • Why the same extra sets that help a healthy young lifter may not help as much once sarcopenic obesity is already present
  • What matters more than chasing a specific number, according to the research

Anyone who has spent time around gym culture has heard some version of the claim that more sets always means more muscle. It is a tidy idea, and it is not entirely wrong, but the actual research on resistance training volume, meaning how many sets per muscle group a person performs each week, tells a more layered story once you look past general fitness advice and into the specific evidence for sarcopenic obesity. This matters because volume is one of the few resistance training variables a person can adjust without any special equipment, and getting a sense of where the real returns level off can save a lot of wasted time in the gym.

What Training Volume Actually Means

In exercise science, training volume is usually measured as the total number of sets performed for a given muscle group across a week, regardless of how those sets are distributed across sessions. A person doing three sets of squats twice a week has a weekly lower body volume of six sets. This is distinct from training frequency, which refers to how often a muscle group is trained, and from intensity, which refers to how heavy the load is relative to a person's maximum. Researchers separate these variables because each one can, in principle, be dialed up or down independently, and identifying which one actually drives muscle growth has practical value for anyone designing a routine, whether that is a personal trainer, a physiotherapist, or a person managing their own health.

The Landmark Dose Response Meta-Analysis

The most widely cited paper on this question is a 2017 systematic review and meta-analysis by Brad Schoenfeld and colleagues, published in the Journal of Sports Sciences. The researchers pooled 15 studies representing 34 treatment groups and modeled weekly sets per muscle group as a continuous predictor of hypertrophy, meaning measured muscle growth via imaging or biopsy rather than self-reported strength gains. They found a statistically significant, graded relationship: each additional weekly set was associated with roughly a 0.37 percent additional increase in muscle size, and when studies were grouped into low (fewer than five weekly sets), moderate (five to nine), and high (ten or more) categories, there was a trend toward greater gains at higher volumes. The paper became foundational for the now common recommendation that meaningful hypertrophy benefits continue to accrue up to around ten or more sets per muscle group per week, well beyond the single set per exercise that older guidelines once considered sufficient.

Newer Meta-Regressions Add Nuance

Subsequent research has refined rather than overturned this picture. A 2024 meta-regression by Joshua Pelland and colleagues, which pooled 67 studies and more than 2,000 participants, distinguished between sets that directly targeted a muscle and sets that trained it only indirectly, for example through a compound exercise. Using this more precise counting method, the analysis found that the probability of a true positive relationship between volume and hypertrophy was effectively 100 percent, confirming that more direct working sets do tend to produce more growth. But the same analysis found clear diminishing returns, meaning each additional set past a certain point adds progressively less benefit, and training frequency on its own showed a much weaker relationship with hypertrophy than volume did. In plain terms, how many total working sets a muscle receives each week appears to matter more than how those sets are split across the week.

Does the Same Relationship Hold in Sarcopenic Obesity?

This is where the evidence becomes genuinely more uncertain, and where the practical picture for sarcopenic obesity diverges from the general hypertrophy literature above. A 2025 systematic review with meta-regressions by Delaire and colleagues, published in the Journal of Cachexia, Sarcopenia and Muscle, pooled 14 resistance training studies covering 528 older adults, average age about 73, who had been diagnosed with sarcopenia. The researchers specifically tested whether manipulating training variables, including weekly set volume, frequency, intensity, and use of periodization, predicted better muscle mass outcomes. They found that none of these training variables had a statistically significant influence on muscle mass gains. The dominant factor that did predict a smaller hypertrophic response was age itself. The authors concluded that a well-designed, evidence-based resistance training program appears sufficient to induce some hypertrophy in sarcopenic individuals, and that fine-tuning the exact volume prescription does not reliably produce better results in this population, in contrast with what the general hypertrophy literature would predict.

A separate 2025 meta-analysis in Frontiers in Aging Neuroscience, led by Feng and colleagues, pooled seven randomized controlled trials of resistance training specifically in older women with sarcopenic obesity. It found that resistance training significantly reduced body fat percentage and produced clear improvements in physical function tests such as gait speed, the timed up and go test, and chair rise repetitions. However, it found no statistically significant difference in total skeletal muscle mass between the training group and controls. Read alongside the Delaire meta-regression, this suggests that in populations who already have sarcopenic obesity, resistance training reliably improves strength, function, and fat mass, which are meaningful outcomes on their own, but the muscle mass gains that volume manipulation reliably produces in healthy trained lifters are harder to replicate once age related muscle loss is already underway.

Why the Evidence Diverges Between Healthy Lifters and Sarcopenic Populations

Several factors likely explain this gap. Most of the foundational dose response research, including the Schoenfeld and Pelland analyses above, was conducted primarily in younger or middle-aged trained individuals without a diagnosed muscle wasting condition. Older adults with sarcopenia, and by extension many people with sarcopenic obesity, tend to show anabolic resistance, a blunted muscle protein synthesis response to a given stimulus, whether that stimulus is dietary protein or a bout of resistance exercise. Our earlier piece on anabolic resistance and inactivity covers how this blunted response develops, and the same mechanism plausibly explains why simply adding more sets does not translate into proportionally more muscle once this resistance is already present. Chronic low-grade inflammation and higher fat mass, both hallmarks of sarcopenic obesity, are also thought to interfere with the signaling pathways that translate a training stimulus into new muscle protein, which would further dampen any dose response relationship regardless of how carefully the volume is prescribed.

What the Official Guidelines Say

It is worth noting that public health guidelines have not attempted to specify an optimal weekly set count at all. The World Health Organization's 2020 guidelines on physical activity and sedentary behaviour, published in the British Journal of Sports Medicine, recommend that adults perform muscle-strengthening activities involving all major muscle groups on two or more days a week, a strong recommendation based on moderate-certainty evidence. Notably, the guideline authors state explicitly that there was no evidence to support a dose response association with higher volumes of muscle-strengthening activity at the population health level. This is a different question than the hypertrophy-specific dose response research above, since public health guidelines are built around broad outcomes like cardiovascular disease and diabetes risk rather than maximizing muscle size, but it reinforces the same theme: beyond a basic consistent habit, chasing a precise volume target has more evidence behind it for healthy lifters seeking maximal hypertrophy than it does as a general prescription.

Practical Implications for Young Adults

Most readers of this site are not yet dealing with the degree of age related anabolic resistance seen in the sarcopenia trials described above, which is a meaningfully different starting point. For a young adult without a diagnosed muscle wasting condition, the Schoenfeld and Pelland findings are probably the more relevant guide: performing somewhere in the range of ten or more weekly sets per major muscle group, split across two or more sessions, is reasonably well supported for building muscle, though the returns taper off rather than climbing indefinitely. Our earlier post on getting started with strength training covers how to build that habit from zero. But the sarcopenic obesity specific evidence is a useful reminder not to over-index on volume as the single lever that matters. Consistency, adequate protein intake, and simply continuing to train through the years when anabolic resistance can begin to set in appear to matter at least as much as hitting a precise weekly set count, a point our complete guide to sarcopenic obesity in young adults discusses in the context of long-term prevention.

Limitations and What Remains Uncertain

Several caveats apply to this evidence base. The foundational dose response meta-analyses carry substantial heterogeneity between the underlying studies, meaning training protocols, populations, and measurement methods varied considerably, and the confidence intervals around the higher-volume estimates remain wide. The Delaire meta-regression on sarcopenia, while directly relevant, pooled only 14 studies and 528 participants, a modest sample for detecting subtler dose response effects that a larger trial might still uncover, and it did not include participants who additionally had excess adiposity, the second defining feature of sarcopenic obesity specifically, so its findings are extrapolated rather than directly demonstrated for this population. Measurement also matters. Total skeletal muscle mass, the outcome that showed no significant change in the Feng meta-analysis, is a coarser measure than the muscle-specific imaging used in some of the general hypertrophy literature, and it is possible that more sensitive measurements would detect smaller gains that these pooled analyses were underpowered to find. Finally, almost none of this research was conducted in young adults with sarcopenic obesity specifically, since both the sarcopenia and sarcopenic obesity trial literature skew heavily toward participants over 60, which is part of the gap this project's screening of young Omani adults is intended to help address.

Connecting Back to Sarcopenic Obesity

Put together, the evidence suggests a two-part story. In healthy, previously untrained or moderately trained individuals, weekly set volume is a genuine and fairly well quantified lever for building muscle, with benefits that continue, albeit with diminishing returns, up to roughly ten or more sets per muscle group per week. Once sarcopenic obesity or age related anabolic resistance is already established, however, the same volume manipulation appears to lose much of its predictive power over muscle mass specifically, even though resistance training of essentially any reasonable design still delivers real and measurable benefits for strength, physical function, and fat mass. The practical message for prevention, rather than treatment, is that starting and sustaining a resistance training habit early, before this blunted response sets in, may matter considerably more than optimizing the exact number of sets performed each week.

References

This post is for general education and isn't medical advice. Speak with a healthcare provider or qualified exercise professional before starting a new resistance training program, particularly if you have an existing health condition.

← Back to all posts